Serial 78423268
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Jan 2008)
What this means for you
This application is over — abandoned 25 Jan 2008. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78423268
- Mark type
- Design / logo
- Filed
- 21 May 2004
- Published for opposition
- 01 Nov 2005
- Abandoned
- 25 Jan 2008
- Attorney of record
- Michael R. Henson
Goods and services
- Class 001 — Chemicals: Chemicals for use in science and in pharmaceutical manufacture; chemical preparations, namely carriers and excipients in the nature of chemical additives for use in the manufacture of pharmaceuticals
- Class 005 — Pharmaceuticals: Pharmaceutical substances and preparations, namely, anticancer agents; genetic substances for use in treatment of neurodegenerative diseases; chemical preparations, namely carriers and excipients in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic reagents and pharmaceutically active agents for medical research use for treatment of cancer and neurodegenerative disorders
- Class 040 — Treatment of materials: Custom manufacturing services for the preparation of pharmaceuticals and pharmaceutically active materials; processing of pharmaceuticals and pharmaceutically active materials; extraction of chemical substances from plant materials and purification of the crude plant extract; treatment of plant materials for use in research and development and in pharmaceutical manufacture
- Class 042 — Scientific and technological services: Scientific research comprising medical and genetic analysis and investigation of clinical trial recruits for the benefit of pharmaceutical companies; licensing of patents and intellectual property; chemical analysis; scientific and medical research; research services relating to the development and testing of pharmaceuticals; scientific research relating to genetics and oncology; development and licensing of anticancer agents; developing cures for cancer and hereditary disease and diseases involving cellular dysfunction other than cancer and hereditary diseases.
Owner
- Tapestry Pharmaceuticals, Inc., Boulder, CO, US
- Tapestry Pharmaceuticals, Inc., Boulder, CO, US
Prosecution history
- 26 Mar 2008 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 26 Mar 2008 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Jul 2007 — SOU EXTENSION 3 GRANTED
- 23 Jul 2007 — SOU EXTENSION 3 FILED
- 23 Jul 2007 — SOU TEAS EXTENSION RECEIVED
- 13 Dec 2006 — SOU EXTENSION 2 GRANTED
- 13 Dec 2006 — SOU EXTENSION 2 FILED
- 13 Dec 2006 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2006 — SOU EXTENSION 1 GRANTED
- 18 Jul 2006 — SOU EXTENSION 1 FILED
- 18 Jul 2006 — SOU TEAS EXTENSION RECEIVED
- 24 Jan 2006 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 01 Nov 2005 — PUBLISHED FOR OPPOSITION
- 12 Oct 2005 — NOTICE OF PUBLICATION
- 08 Sept 2005 — LAW OFFICE PUBLICATION REVIEW COMPLETED